Demonstrates improved mechanical and antibacterial properties in polylactic acid composites, suggesting potential applications in biodegradable materials.
This study presents a novel modified polylactic acid (PLA) composite material engineered to simultaneously achieve enhanced mechanical performance, crystallinity, degradability, and antibacterial activity through the incorporation of multi-arm Zn/CFR-PLA modifiers, derived from ZnO-loaded phenolic resin microspheres. The modifiers were synthesized via ring-opening polymerization (ROP) of lactide, initiated by phenolic resin microspheres with multiple surface hydroxyl groups, where multi-arm architecture was tailored to improve compatibility and interfacial bonding with PLA matrices. Mechanical characterization revealed significant reinforcement and toughening effects: the (Zn/CFR2-PLLA)2/PLLA composite exhibited an elongation at break of 102.7% (≈13-fold higher than pristine PLA) and a tensile strength of 19.6 MPa, alongside markedly improved impact strength. Notably, the Zn/CFR2-PDLA/PLLA composite, leveraging stereocomplex formation between PDLA and PLLA, achieved a higher tensile strength of 27.2 MPa with an elongation at break of 47.3%. Furthermore, the release of zinc ions from the modifiers endowed the composites with exceptional antibacterial activity, achieving more than 98% inhibition against Escherichia coli and Staphylococcus aureus. The composites also demonstrated degradability and processability, as melt-spun PLA fibers derived from them exhibited enhanced modulus (up to 4.51 GPa) and moisture-wicking capability. The composites can serve as potential candidates for biodegradable packaging films, antibacterial textiles for medical or hygienic uses, and sustainable materials for consumer products.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: